Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW conjugate vaccine in participants aged 12 months and older in Vietnam
NCT06228586Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2024
- Primary completion
- Mar 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Jan 2024; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT06228586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06228586.